PEDIATRICS Vol. 100 No. 4 October 1997, pp. 593-599

Multicenter Controlled Clinical Trial of High-frequency Jet Ventilation in Preterm Infants With Uncomplicated Respiratory Distress Syndrome

Received Oct 24, 1996; accepted Feb 28, 1997.

Martin Keszler^*, Houchang D. Modanlou, D. Spencer Brudno^§, Frank I. Clark, Ronald S. Cohen^¶, Rita M. Ryan^#, Mark K. Kaneta^**, and Jonathan M. Davis

From the Departments of Pediatrics, ^* Georgetown University, Washington, DC;  University of California at Irvine, Irvine, California; ^§ Medical College of Georgia, Augusta, Georgia;  University of Missouri, Columbia, Missouri; ^¶ Stanford University, Stanford, California; ^# University of Rochester, Rochester, New York; ^** University Medical Center of Southern Nevada, Las Vegas, Nevada; and  Winthrop University Hospital, SUNY Stony Brook School of Medicine, Mineola, New York.

Objective.  To test the hypothesis that high-frequency jet ventilation (HFJV) will reduce the incidence and/or severity of bronchopulmonary dysplasia (BPD) and acute airleak in premature infants who, despite surfactant administration, require mechanical ventilation for respiratory distress syndrome.

Design.  Multicenter, randomized, controlled clinical trial of HFJV and conventional ventilation (CV). Patients were to remain on assigned therapy for 14 days or until extubation, whichever came first. Crossover from CV to HFJV was allowed if bilateral pulmonary interstitial emphysema or bronchopleural fistula developed. Patients could cross over to the other ventilatory mode if failure criteria were met. The optimal lung volume strategy was mandated for HFJV by protocol to provide alveolar recruitment and optimize lung volume and ventilation/perfusion matching, while minimizing pressure amplitude and O₂ requirements. CV management was not controlled by protocol.

Setting.  Eight tertiary neonatal intensive care units.

Patients.  Preterm infants with birth weights between 700 and 1500 g and gestational age <36 weeks who required mechanical ventilation with FIO₂ >0.30 at 2 to 12 hours after surfactant administration, received surfactant by 8 hours of age, were <20 hours old, and had been ventilated for <12 hours.

Outcome Measures.  Primary outcome variables were BPD at 28 days and 36 weeks of postconceptional age. Secondary outcome variables were survival, gas exchange, airway pressures, airleak, intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), and other nonpulmonary complications.

Results.  A total of 130 patients were included in the final analysis; 65 were randomized to HFJV and 65 to CV. The groups were of comparable birth weight, gestational age, severity of illness, postnatal age, and other demographics. The incidence of BPD at 36 weeks of postconceptional age was significantly lower in babies randomized to HFJV compared with CV (20.0% vs 40.4%). The need for home oxygen was also significantly lower in infants receiving HFJV compared with CV (5.5% vs 23.1%). Survival, incidence of BPD at 28 days, retinopathy of prematurity, airleak, pulmonary hemorrhage, grade I-II IVH, and other complications were similar. In retrospect, it was noted that the traditional HFJV strategy emphasizing low airway pressures (HF-LO) rather than the prescribed optimal volume strategy (HF-OPT) was used in 29/65 HFJV infants. This presented a unique opportunity to examine the effects of different HFJV strategies on gas exchange, airway pressures, and outcomes. HF-OPT was defined as increase in positive end-expiratory pressure (PEEP) by 1 cm H₂O from pre-HFJV baseline and/or use of PEEP of 7 cm H₂O. Severe neuroimaging abnormalities (PVL and/or grade III-IV IVH) were not different between the CV and HFJV infants. However, there was a significantly lower incidence of severe IVH/PVL in HFJV infants treated with HF-OPT compared with CV and HF-LO. Oxygenation was similar between CV and HFJV groups as a whole, but HF-OPT infants had better oxygenation compared with the other two groups. There were no differences in PaCO₂ between CV and HFJV, but the PaCO₂ was lower for HF-LO compared with the other two groups. The peak inspiratory pressure and P (peak inspiratory pressure-PEEP) were lower for HFJV infants compared with CV infants.

Conclusions.  HFJV reduces the incidence of BPD at 36 weeks and the need for home oxygen in premature infants with uncomplicated RDS, but does not reduce the risk of acute airleak. There is no increase in adverse outcomes compared with CV. HF-OPT improves oxygenation, decreases exposure to hypocarbia, and reduces the risk of grade III-IV IVH and/or PVL.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. J. E. Schuerer, N. S. Kolovos, K. V. Boyd, and C. M. Coopersmith Extracorporeal Membrane Oxygenation: Current Clinical Practice, Coding, and Reimbursement Chest, July 1, 2008; 134(1): 179 - 184. [Abstract] [Full Text] [PDF]

				M. Keszler High-frequency Ventilation: Evidence-based Practice and Specific Clinical Indications NeoReviews, May 1, 2006; 7(5): e234 - e249. [Full Text] [PDF]

				S M Donn and S K Sinha Minimising ventilator induced lung injury in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2006; 91(3): F226 - F230. [Abstract] [Full Text] [PDF]

				U H Thome, W A Carlo, and F Pohlandt Ventilation strategies and outcome in randomised trials of high frequency ventilation Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2005; 90(6): F466 - F473. [Abstract] [Full Text] [PDF]

				C. W. Bollen, C. S. P. M. Uiterwaal, and A. J. van Vught Cumulative Metaanalysis of High-frequency Versus Conventional Ventilation in Premature Neonates Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1150 - 1155. [Full Text] [PDF]

				S. E. Courtney, D. J. Durand, J. M. Asselin, M. L. Hudak, J. L. Aschner, C. T. Shoemaker, and the Neonatal Ventilation Study Group High-Frequency Oscillatory Ventilation versus Conventional Mechanical Ventilation for Very-Low-Birth-Weight Infants N. Engl. J. Med., August 29, 2002; 347(9): 643 - 652. [Abstract] [Full Text] [PDF]

				D. R. Gerstmann, K. Wood, A. Miller, M. Steffen, B. Ogden, R. A. Stoddard, and S. D. Minton Childhood Outcome After Early High-Frequency Oscillatory Ventilation for Neonatal Respiratory Distress Syndrome Pediatrics, September 1, 2001; 108(3): 617 - 623. [Abstract] [Full Text] [PDF]

				G. Moriette, J. Paris-Llado, H. Walti, B. Escande, J.-F. Magny, G. Cambonie, G. Thiriez, S. Cantagrel, T. Lacaze-Masmonteil, L. Storme, et al. Prospective Randomized Multicenter Comparison of High-Frequency Oscillatory Ventilation and Conventional Ventilation in Preterm Infants of Less Than 30 Weeks With Respiratory Distress Syndrome Pediatrics, February 1, 2001; 107(2): 363 - 372. [Abstract] [Full Text]

				B. A. YODER, T. SILER-KHODR, V. T. WINTER, and J. J. COALSON High-frequency Oscillatory Ventilation . Effects on Lung Function, Mechanics, and Airway Cytokines in the Immature Baboon Model for Neonatal Chronic Lung Disease Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1867 - 1876. [Abstract] [Full Text]

				J. A. Krishnan and R. G. Brower High-Frequency Ventilation for Acute Lung Injury and ARDS Chest, September 1, 2000; 118(3): 795 - 807. [Abstract] [Full Text] [PDF]

				E. C. Eichenwald and A. R. Stark High-frequency Ventilation: Current Status Pediatr. Rev., December 1, 1999; 20(12): e127 - e133. [Full Text] [PDF]

				F. Cools and M. Offringa Meta-analysis of elective high frequency ventilation in preterm infants with respiratory distress syndrome Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1999; 80(1): 15F - 20. [Abstract] [Full Text]

				M. Caplan, W. MacKendrick;, and M. Keszler High-frequency Jet Ventilation in Preterm Infants Pediatrics, July 1, 1998; 102(1): 158a - 159. [Full Text]